Əsas səhifə

Çap

Əks əlaqə

İnfo
Oral steroids in idiopathic sudden sensorineural hearing loss

Mündəricat

Oral steroids in idiopathic sudden sensorineural hearing loss

Sübutlu məlumatların xülasələri
14.07.2017 • Sonuncu dəyişiklik 14.07.2017
Editors

The efficacy of steroids in the treatment of idiopathic sudden sensorineural hearing loss is unclear.

A Cochrane review included 3 studies with a total of 253 subjects. One trial (n=21) showed a lack of effect of oral steroids in improving hearing compared with the placebo control group (RR 0.94, 95% CI 0.48 to 1.85). The second trial (n=129) showed a significant improvement of hearing in 61% of the patients receiving oral steroid and in only 32% of the patients from the control group (RR 1.30, 95% CI 0.91 to 1.86). The third trial (n=103) also showed a lack of effect of oral steroids in improving hearing compared with the placebo control. Only one study declared that no patients suffered from adverse effects of the steroid treatment.

Comment:The quality of evidence is downgraded by study quality (inadequate allocation concealment), imprecise results (limited study size for each comparison) and inconsistency (heterogeneity in patients and interventions).

Ədəbiyyat

  1. Wei BP, Stathopoulos D, O'Leary S. Steroids for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev 2013;7():CD003998. .